MiR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes

Journal of Investigative Dermatology

Volumn 133, Issue 3, 2013, Pages 768-775

  Luo, Chonglin ^a   Tetteh, Paul W ^a,f   Merz, Patrick R ^a   Dickes, Elke ^a   Abukiwan, Alia ^a   Hotz Wagenblatt, Agnes ^a   Holland Cunz, Stefan ^b   Sinnberg, Tobias ^c   Schittek, Birgit ^c   Schadendorf, Dirk ^d   Diederichs, Sven ^e   Eichmüller, Stefan B ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f HUBRECHT INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; PROTEIN BCL 2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; Y BOX BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; DOWN REGULATION; ENHANCER REGION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 84873711992     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.357     Document Type: Article

References (46)

1. Bachmann IM, Halvorsen OJ, Collett K et al. (2006) EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 24: 268-73
2. Balch CM, Buzaid AC, Soong SJ et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19: 3635-48
3. Bell RE, Levy C (2011) The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. Pigment Cell Melanoma Res 24: 1088-106
4. Bemis LT, Chen R, Amato CM et al. (2008) MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 68: 1362-8
5. Beuret L, Flori E, Denoyelle C et al. (2007) Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis. J Biol Chem 282: 14140-7
6. Carreira S, Goodall J, Denat L et al. (2006) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20: 3426-39
7. Cheli Y, Ohanna M, Ballotti R et al. (2010) Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell Melanoma Res 23: 27-40
8. Chen Q, Chen X, Zhang M et al. (2011a) miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci 56: 2009-16
9. Chen X, Wang J, Shen H et al. (2011b) Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma. Invest Ophthalmol Vis Sci 52: 1193-9
10. Deng Y, Deng H, Bi F et al. (2011) MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int J Biol Sci 7: 133-7
11. Dynek JN, Chan SM, Liu J et al. (2008) Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. Cancer Res 68: 3124-32
12. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-79
13. Garraway LA, Widlund HR, Rubin MA et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-22
14. Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445: 851-7
15. Hoek KS, Eichhoff OM, Schlegel NC et al. (2008) In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68: 650-6
16. Hoek KS, Schlegel NC, Brafford P et al. (2006) Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 19: 290-302
17. Huang JC, Babak T, Corson TW et al. (2007) Using expression profiling data to identify human microRNA targets. Nat Methods 4: 1045-9
18. John B, Enright AJ, Aravin A et al. (2004) Human microRNA targets. PLoS Biol 2: e363
19. Kohno K, Izumi H, Uchiumi T et al. (2003) The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25: 691-8
20. Krek A, Grun D, Poy MN et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500
21. Langevin SM, Stone RA, Bunker CH et al. (2011) MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. Cancer 117: 1454-62
22. Levy C, Khaled M, Fisher DE (2006) MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12: 406-14
23. Lewis BP, Shih IH, Jones-Rhoades MW et al. (2003) Prediction of mammalian microRNA targets. Cell 115: 787-98
24. Li G, Schaider H, Satyamoorthy K et al. (2001) Downregulation of E-cadherin and desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene 20: 8125-35
25. Lim LP, Lau NC, Garrett-Engele P et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-73
26. Liu M, Lang N, Qiu M et al. (2011) miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int J Cancer 128: 1269-79
27. Liu X, Yao W, Newton RC et al. (2008) Targeting the c-MET signaling pathway for cancer therapy. Expert Opin Investig Drugs 17: 997-1011
28. Mascarenhas JB, Littlejohn EL, Wolsky RJ et al. (2010) PAX3 and SOX10 activate MET receptor expression in melanoma. Pigment Cell Melanoma Res 23: 225-37
29. McGill GG, Haq R, Nishimura EK et al. (2006) c-Met expression is regulated by MITF in the melanocyte lineage. J Biol Chem 281: 10365-73
30. Miller AJ, Mihm MC Jr (2006) Melanoma. N Engl J Med 355: 51-65
31. Mueller DW, Bosserhoff AK (2010) The evolving concept of "melanomiRs"-microRNAs in melanomagenesis. Pigment Cell Melanoma Res 23: 620-6
32. Mueller DW, Rehli M, Bosserhoff AK (2009) miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 129: 1740-51
33. Oliver FJ, de la Rubia G, Rolli V et al. (1998) Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273: 33533-9
34. Philippidou D, Schmitt M, Moser D et al. (2010) Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer Res 70: 4163-73
35. Puri N, Ahmed S, Janamanchi V et al. (2007) c-Met is a potentially new therapeutic target for treatment of human melanoma. Clin Cancer Res 13: 2246-53
36. Schittek B, Psenner K, Sauer B et al. (2007) The increased expression of Y boxbinding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance. Int J Cancer 120: 2110-8
37. Seggerson K, Tang L, Moss EG (2002) Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev Biol 243: 215-25
38. Silber J, Lim DA, Petritsch C et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14
39. Smrt RD, Szulwach KE, Pfeiffer RL et al. (2010) MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 28: 1060-70
40. Soengas MS, Lowe SW (2003) Apoptosis and melanoma chemoresistance. Oncogene 22: 3138-51
41. Strub T, Giuliano S, Ye T et al. (2011) Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30: 2319-32
42. Szulwach KE, Li X, Smrt RD et al. (2010) Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 189: 127-41
43. Tolbert WD, Daugherty-Holtrop J, Gherardi E et al. (2010) Structural basis for agonism and antagonism of hepatocyte growth factor. Proc Natl Acad Sci USA 107: 13264-9
44. Tonini T, D'Andrilli G, Fucito A et al. (2008) Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements. J Cell Physiol 214: 295-300
45. Tsao H, Atkins MB, Sober AJ (2004) Management of cutaneous melanoma. N Engl J Med 351: 998-1012
46. Winter J, Jung S, Keller S et al. (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11: 228-34